[Phytohaemagglutinin culture as a serial control of lymphoproliferative diseases (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D006801:Humans; D007111:Immunity, Cellular; D037102:Lectins; D007958:Leukocyte Count; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D008875:Middle Aged; D012008:Recurrence
D000970:Antineoplastic Agents; D037102:Lectins
Die Phytohämagglutininkultur als Test zur Verlaufskontrolle lymphoproliferativer Erkrankungen